Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1084)
All Articles published online
|
Publishing Process of This Article
|
Mar 7, 2024 (publication date) through Jun 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Colapietro F, Pugliese N, Voza A, Aghemo A, De Nicola S. Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis. World J Gastroenterol 2024; 30(9): 1253-1256 [PMID: 38577192 DOI: 10.3748/wjg.v30.i9.1253] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i9/1253.htm |
| Number | Citing Articles |
| 1 |
Wei-Nung Liu, Ming-Shen Dai, Felicia Lin, Gen-Min Lin. Navigating the complex terrain of hepatitis B virus reactivation in the era of Bruton tyrosine kinase inhibitors. World Journal of Gastroenterology 2024; 30(21): 2748-2750 doi: 10.3748/wjg.v30.i21.2748
|
| 2 |
|
| 3 |
Bansi P Savaliya, Ramin Shekouhi, Fatima Mubarak, Harsheen K Manaise, Paola Berrios Jimenez, Gabrielle Kowkabany, Reed A Popp, Kyle Popp, Emmanuel Gabriel. Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors. World Journal of Gastroenterology 2024; 30(24): 3052-3058 doi: 10.3748/wjg.v30.i24.3052
|